 | • レポートコード：GIR-2104Z01001 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗肥満薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗肥満薬の種類別市場規模（処方薬、OTC薬）、用途別市場規模（小児期（0-6）、少年（7-17）、青年（18-40）、中年（41-60）、高齢者（60歳以上））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗肥満薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Zafgan、Vivus、Shionogi、Sanofi、Rhythm Pharmaceuticals、Pfizer、Orexigen Therapeutics、Novo Nordisk、Norgine、Nalpropion Pharmaceuticals Inc.、Merck、GlaxoSmithKline、F.Hoffmann-La Roche、Eisai、Boehringer Ingelheim、Bayer AG、AstraZeneca、Arena Pharmaceuticals、Amylin、Alizyme ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：処方薬、OTC薬 ・用途別分析2016年-2026年：小児期（0-6）、少年（7-17）、青年（18-40）、中年（41-60）、高齢者（60歳以上） ・抗肥満薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗肥満薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗肥満薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗肥満薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗肥満薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-Obesity Drugs (Anti-obesity Medication) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-Obesity Drugs (Anti-obesity Medication) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti-Obesity Drugs (Anti-obesity Medication) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti-Obesity Drugs (Anti-obesity Medication) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drugs
OTC Drugs
Market segment by Application can be divided into
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
The key market players for global Anti-Obesity Drugs (Anti-obesity Medication) market are listed below:
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Childhood (0-6)
1.3.3 Juvenile (7-17)
1.3.4 Youth (18-40)
1.3.5 Middle Aged (41-60)
1.3.6 Elderly (Above 60)
1.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size & Forecast
1.4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales in Value (2016-2026))
1.4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume (2016-2026)
1.4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity Analysis
1.5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Total Production Capacity (2016-2026)
1.5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
1.6.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
1.6.3 Anti-Obesity Drugs (Anti-obesity Medication) Trends Analysis
2 Manufacturers Profiles
2.1 Zafgan
2.1.1 Zafgan Details
2.1.2 Zafgan Major Business
2.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Vivus
2.2.1 Vivus Details
2.2.2 Vivus Major Business
2.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Shionogi
2.3.1 Shionogi Details
2.3.2 Shionogi Major Business
2.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Rhythm Pharmaceuticals
2.5.1 Rhythm Pharmaceuticals Details
2.5.2 Rhythm Pharmaceuticals Major Business
2.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Orexigen Therapeutics
2.7.1 Orexigen Therapeutics Details
2.7.2 Orexigen Therapeutics Major Business
2.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novo Nordisk
2.8.1 Novo Nordisk Details
2.8.2 Novo Nordisk Major Business
2.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Norgine
2.9.1 Norgine Details
2.9.2 Norgine Major Business
2.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Nalpropion Pharmaceuticals Inc.
2.10.1 Nalpropion Pharmaceuticals Inc. Details
2.10.2 Nalpropion Pharmaceuticals Inc. Major Business
2.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 F.Hoffmann-La Roche
2.13.1 F.Hoffmann-La Roche Details
2.13.2 F.Hoffmann-La Roche Major Business
2.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Eisai
2.14.1 Eisai Details
2.14.2 Eisai Major Business
2.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Boehringer Ingelheim
2.15.1 Boehringer Ingelheim Details
2.15.2 Boehringer Ingelheim Major Business
2.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Bayer AG
2.16.1 Bayer AG Details
2.16.2 Bayer AG Major Business
2.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 AstraZeneca
2.17.1 AstraZeneca Details
2.17.2 AstraZeneca Major Business
2.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Arena Pharmaceuticals
2.18.1 Arena Pharmaceuticals Details
2.18.2 Arena Pharmaceuticals Major Business
2.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Amylin
2.19.1 Amylin Details
2.19.2 Amylin Major Business
2.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Alizyme
2.20.1 Alizyme Details
2.20.2 Alizyme Major Business
2.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
2.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturer
3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti-Obesity Drugs (Anti-obesity Medication)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturer Market Share
3.4.2 Top 6 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturer Market Share
3.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti-Obesity Drugs (Anti-obesity Medication) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Region (2016-2026)
4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2016-2026)
4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026)
4.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026)
4.4 Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026)
4.5 South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026)
4.6 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Type (2016-2026)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2016-2026)
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Application (2016-2026)
6.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2016-2026)
6.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2026)
7.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2026)
7.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
7.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Country (2016-2026)
7.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2026)
8.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2026)
8.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
8.3.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2026)
9.2 Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2026)
9.3 Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
9.3.1 Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2026)
10.2 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2026)
10.3 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
10.3.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Country (2016-2026)
10.3.2 South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2026)
11.2 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2026)
11.3 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
11.3.1 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti-Obesity Drugs (Anti-obesity Medication) Typical Distributors
12.3 Anti-Obesity Drugs (Anti-obesity Medication) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application, (USD Million), 2021-2026
Table 3. Zafgan Basic Information, Manufacturing Base and Competitors
Table 4. Zafgan Major Business
Table 5. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 6. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Vivus Basic Information, Manufacturing Base and Competitors
Table 8. Vivus Major Business
Table 9. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 10. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Shionogi Basic Information, Manufacturing Base and Competitors
Table 12. Shionogi Major Business
Table 13. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 14. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 18. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Rhythm Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Rhythm Pharmaceuticals Major Business
Table 21. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 22. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 26. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Orexigen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Orexigen Therapeutics Major Business
Table 29. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 30. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 32. Novo Nordisk Major Business
Table 33. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 34. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Norgine Basic Information, Manufacturing Base and Competitors
Table 36. Norgine Major Business
Table 37. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 38. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Nalpropion Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Nalpropion Pharmaceuticals Inc. Major Business
Table 41. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 42. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 46. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 48. GlaxoSmithKline Major Business
Table 49. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 50. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. F.Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 52. F.Hoffmann-La Roche Major Business
Table 53. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 54. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Eisai Basic Information, Manufacturing Base and Competitors
Table 56. Eisai Major Business
Table 57. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 58. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 60. Boehringer Ingelheim Major Business
Table 61. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 62. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 64. Bayer AG Major Business
Table 65. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 66. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 70. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Arena Pharmaceuticals Major Business
Table 73. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 74. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Amylin Basic Information, Manufacturing Base and Competitors
Table 76. Amylin Major Business
Table 77. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 78. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Alizyme Basic Information, Manufacturing Base and Competitors
Table 80. Alizyme Major Business
Table 81. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product and Services
Table 82. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturer (2019-2021e) & (K Units)
Table 84. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 85. Market Position of Manufacturers in Anti-Obesity Drugs (Anti-obesity Medication), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 86. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Anti-Obesity Drugs (Anti-obesity Medication) Production Site of Key Manufacturer
Table 88. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2016-2021e) & (K Units)
Table 89. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2021-2026) & (K Units)
Table 90. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2016-2021e) & (USD Million)
Table 91. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2021-2026) & (USD Million)
Table 92. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021e) & (K Units)
Table 93. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2021-2026) & (K Units)
Table 94. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2016-2021e) & (USD Million)
Table 95. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2021-2026) & (USD Million)
Table 96. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2016-2021e) & (USD/Unit)
Table 97. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2021-2026) & (USD/Unit)
Table 98. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021e) & (K Units)
Table 99. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2021-2026) & (K Units)
Table 100. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2016-2021e) & (USD Million)
Table 101. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2021-2026) & (USD Million)
Table 102. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2016-2021e) & (USD/Unit)
Table 103. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2021-2026) & (USD/Unit)
Table 104. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2016-2021e) & (K Units)
Table 105. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2021-2026) & (K Units)
Table 106. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2021e) & (USD Million)
Table 107. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2021-2026) & (USD Million)
Table 108. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021e) & (K Units)
Table 109. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2021-2026) & (K Units)
Table 110. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021e) & (K Units)
Table 111. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2021-2026) & (K Units)
Table 112. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2016-2021e) & (K Units)
Table 113. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2021-2026) & (K Units)
Table 114. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2021e) & (USD Million)
Table 115. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2021-2026) & (USD Million)
Table 116. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021e) & (K Units)
Table 117. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2021-2026) & (K Units)
Table 118. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021e) & (K Units)
Table 119. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2021-2026) & (K Units)
Table 120. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2016-2021e) & (K Units)
Table 121. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2021-2026) & (K Units)
Table 122. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2016-2021e) & (USD Million)
Table 123. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2021-2026) & (USD Million)
Table 124. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021e) & (K Units)
Table 125. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2021-2026) & (K Units)
Table 126. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021e) & (K Units)
Table 127. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2021-2026) & (K Units)
Table 128. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2016-2021e) & (K Units)
Table 129. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2021-2026) & (K Units)
Table 130. South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2021e) & (USD Million)
Table 131. South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2021-2026) & (USD Million)
Table 132. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021e) & (K Units)
Table 133. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2021-2026) & (K Units)
Table 134. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021e) & (K Units)
Table 135. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2021-2026) & (K Units)
Table 136. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2016-2021e) & (K Units)
Table 137. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2021-2026) & (K Units)
Table 138. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2016-2021e) & (USD Million)
Table 139. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2021-2026) & (USD Million)
Table 140. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2016-2021e) & (K Units)
Table 141. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2021-2026) & (K Units)
Table 142. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2016-2021e) & (K Units)
Table 143. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2021-2026) & (K Units)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Anti-Obesity Drugs (Anti-obesity Medication) Typical Distributors
Table 147. Anti-Obesity Drugs (Anti-obesity Medication) Typical Customers
List of Figures
Figure 1. Anti-Obesity Drugs (Anti-obesity Medication) Picture
Figure 2. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type in 2020
Figure 3. Prescription Drugs
Figure 4. OTC Drugs
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2020
Figure 6. Childhood (0-6)
Figure 7. Juvenile (7-17)
Figure 8. Youth (18-40)
Figure 9. Middle Aged (41-60)
Figure 10. Elderly (Above 60)
Figure 11. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Anti-Obesity Drugs (Anti-obesity Medication) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (2016-2026) & (K Units)
Figure 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity (2016-2026) & (K Units)
Figure 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
Figure 36. Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
Figure 37. Anti-Obesity Drugs (Anti-obesity Medication) Market Trends
Figure 38. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturer in 2020
Figure 39. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturer in 2020
Figure 40. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2016-2026)
Figure 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2016-2026)
Figure 45. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026) & (USD Million)
Figure 46. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026) & (USD Million)
Figure 48. South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue (2016-2026) & (USD Million)
Figure 50. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2026)
Figure 51. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2016-2026)
Figure 52. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2026)
Figure 54. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2016-2026)
Figure 55. Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2016-2026)
Figure 57. North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2016-2026)
Figure 58. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2026)
Figure 59. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2026)
Figure 60. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2016-2026)
Figure 61. Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2016-2026)
Figure 62. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2026)
Figure 63. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2026)
Figure 68. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2016-2026)
Figure 69. South America Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2016-2026)
Figure 70. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2026)
Figure 71. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の抗肥満処方薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界の抗肥満薬市場規模・現状・予測（2021年-2027年） Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. Market Analysis and Insights: Global Anti-obesity Medicine Market The global Anti-obesity Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a …
- 抗肥満薬の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Anti-obesity Drug from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 202…
- 世界の抗インフルエンザ薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-influenza Drugs Market The global Anti-influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…